The downgrade is the result of a number of factors, including the medical center’s decline in operating performance in fiscal year 2016 and continued poor performance through the first nine months of fiscal year 2017.
The outlook is stable, reflecting Moody’s Investors Service’s expectation the medical center will not experience a further decline in operating performance relative to anticipated fiscal year 2017 levels.
More articles on healthcare finance:
S&P revises Orlando Health’s outlook to positive
S&P assigns ‘AA’ rating to CHOP’s bonds
Fitch assigns ‘AA’ rating to Duke University Health System’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
